Annals of hepatology (1117 documentos)


121.-
Liver iron concentration is not raised in patients with dysmetabolic hyperferritinemia
Castiella, Agustin1; Zapata, Eva1; Zubiaurre, Leire1; Iribarren, Arantxa1; Alústiza, Jose M2; Otazua, Pedro3; Salvador, Emma2; Emparanza, Jose I4
1Hospital de Mendaro, Servicio de Gastroenterología, Mendaro, Guipúzcoa. España; 2Osatek Donostia, Servicio de Radiología, San Sebastián, Guipúzcoa. España; 3Hospital de Mondragón, Servicio de Gastroenterología, Mondragón, Guipúzcoa. España; 4Hospital Universitario de Donostia, Unidad de Epidemiología Clínica, San Sebastián, Guipúzcoa. España
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 540-544]

122.-
123.-
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation
Yang, Chun1; Qin, Bo1; Yuan, Zhe1; Chen, Limin2; Zhou, Hong-yu1
1Chongqing Medical University, The First Affiliated Hospital, Chongquing, Sichuan. China; 2University of Toronto, Toronto General Research Institute, Toronto, Ontario. Canadá
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 501-511]

124.-
125.-
126.-
Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy
Moretti, Rita1; Gazzin, Silvia2; Saveria Croce, Lory2; Baso, Beatrice1; Masutti, Flora2; Bedogni, Giorgio2; Tiribelli, Claudio2
1Universita di Trieste, Clinica di Neurologia, Trieste, Friuli Venezia Giuli. Italia; 2Fundacion Italiana di Fegato, Centro Studi Fegato, Trieste, Friuli Venezia Giuli. Italia
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 559-567]

127.-
128.-
129.-
XI national meeting of the Mexican Association of Hepatology
[Annals of hepatology, México, 2016 Vol. 15 Num. 4 Jul-Ago, Pàg. 619-655]

130.-
131.-
132.-
133.-
Cultural validation of the post-Liver transplant quality of life (pLTQ) questionnaire for the Brazilian population
Molski, Cibele1; Mattiello, Rita2; Sarria, Edgar E3; Saab, Sammy4; Medeiros, Renata1; Brandao, Ajacio1
1Universidade Federal de Ciencias da Saude de Porto Alegre, Faculdade de Medicina, Porto Alegre, Rio Grande do Sul. Brasil; 2Pontificia Universidade Catolica do Rio Grande do Sul, Instituto de Pesquisa Biomedica, Porto Alegre, Rio Grande do Sul. Brasil; 3Universidade de Santa Cruz do Sul, Faculdade de Medicina, Santa Cruz, Rio Grande do Sul. Brasil; 4David Geffen School of Medicine, Department of Medicine and Surgery, Los Angeles, California. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 377-385]

134.-
Cytokeratin19 positive hepatocellular carcinoma is associated with increased peritumoral ductular reaction
Cai, Xiaobo1; Feng, Li2; Liu, Heng1; Xu, Mingyi1; Qu, Yin1; Wan, Xinjian1; Gao, Chunfang3; Lu, Lungen1
1Shanghai Jiaotong University, School of Medicine, Shanghai. China; 2Fudan University, Zhongshan Hospital, Shanghai. China; 3Second Military Medical University, Eastern Hepatobiliary Surgery Hospital, Shanghai. China
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 386-393]

135.-
Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis
Singh, Siddharth1; Venkatesh, Sudhakar K2; Keaveny, Andrew3; Keaveny, Sharon4; Miller, Frank H4; Asbach, Patrick5; Godfrey, Edmund M6; Silva, Alvin C2; Wang, Zhen7; Hassan Murad, Mohammad7; Asrani, Sumeet K8; Lomas, David J6; Ehman, Richard L2
1Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota. Estados Unidos de América; 2Mayo Clinic, Department of Radiology, Rochester, Minnesota. Estados Unidos de América; 3Mayo Clinic, Department of Transplant Surgery, Jacksonville, Florida. Estados Unidos de América; 4Northwestern University Feinberg, School of Medicine, Chicago, Illinois. Estados Unidos de América; 5Charite Universitatsmedizin Berlin, Department of Radiology, Berlín. Alemania; 6Addenbrooke's Hospital, Department of Radiology, Cambridge, Cambridgeshire. Reino Unido; 7Mayo Clinic, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, Minnesota. Estados Unidos de América; 8Baylor University Medical Center, Division of Hepatology, Dallas, Texas. Estados Unidos de América
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 363-376]

136.-
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
Jensen, Donald M1; Asselah, Tarik2; Dieterich, Douglas3; Foster, Graham R4; Sulkowski, Mark S5; Zeuzem, Stefan6; Mantry, Parvez7; Yoshida, Eric M8; Moreno, Christophe9; Ouzan, Denis10; Wright, Mark11; Morano, Luis E12; Buynak, Robert13; Bourliere, Marc14; Hassanein, Tarek15; Nishiguchi, Shuhei16; Kao, Jia-Horng17; Omata, Masao18; Paik, Seung W19; Wong, David K20; Tam, Edward21; Kaita, Kelly22; Feinman, S. Victor23; Stern, Jerry O24; Scherer, Joseph24; Quinson, Anne-Marie24; Voss, Florian25; Gallivan, John-Paul25; Bocher, Wulf O25; Ferenci, Peter26
1University of Chicago, Chicago, Illinois. Estados Unidos de América; 2University Paris-Diderot, Clichy. Francia; 3Icahn School of Medicine at Mount Sinai, Nueva York. Estados Unidos de América; 4Queen Mary University of London, Londres. Reino Unido; 5Johns Hopkins University, School of Medicine, Baltimore, Maryland. Estados Unidos de América; 6J.W. Goethe Universitat, University Hospital, Frankfurt, Hessen. Alemania; 7Methodist Dallas Medical Center, The Liver Institute , Dallas, Texas. Estados Unidos de América; 8University of British Columbia, Vancouver, Columbia Británica. Canadá; 9Universite Libre de Bruxelles, CUB Hopital Erasme, Bruselas. Bélgica; 10Institut Arnault Tzanck, Niza, Alpes Marítimos. Francia; 11Wellcome Trust Clinical Research Facility, Southampton, Hampshire. Reino Unido; 12Hospital Meixoeiro, Vigo, Pontevedra. España; 13Northwest Indiana Center for Clinical Research, Valparaiso, Indiana. Estados Unidos de América; 14Hopital Saint Joseph, Marseille, Bouches-du-Rhone. Francia; 15Southern California Liver Centers, Coronado, California. Estados Unidos de América; 16Hyogo College of Medicine, Hyogo. Japón; 17National Taiwan University Hospital, Taipei. Taiwán; 18Yamanashi Central and Kita Hospitals, Yamanashi, Honshu. Japón; 19Sungkyunkwan University, Samsung Medical Center, Seúl. Corea del Sur; 20Toronto Western Hospital, Liver Center, Toronto, Ontario. Canadá; 21LAIR Centre, Vancouver, Columbia Británica. Canadá; 22HSC University of Manitoba, Winnipeg, Manitoba. Canadá; 23University of Toronto, Mount Sinai Hospital, Toronto, Ontario. Canadá; 24Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut. Estados Unidos de América; 25Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim. Alemania; 26Medical University of Vienna, Viena. Austria
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 333-349]

137.-
138.-
Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction
Bessone, Fernando1; Roma, Marcelo Gabriel2
1Universidad del Rosario, Facultad de Ciencias Médicas, Rosario, Santa Fe. Argentina; 2Universidad del Rosario, Facultad de Ciencias Bioquímicas y Farmacéuticas, Rosario, Santa Fe. Argentina
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 442-447]

139.-
140.-
Liver stiffness assessed by transient elastography in patients with β thalassaemia major
Ferraioli, Giovanna1; Lissandrin, Raffaella1; Tinelli, Carmine2; Scudeller, Luigia2; Bonetti, Federico3; Zicchetti, Mabel1; Longo, Filomena4; Murgia, Mauro5; Bernuzzi, Stefano6; Zecca, Marco3; Casula, Paolo5; Piga, Antonio4; Filice, Carlo1
1Universita di Pavia, Pavia, Lombardia. Italia; 2Fondazione IRCCS Policlinico San Matteo, Clinical Epidemiology and Biometric Unit, Pavia, Lombardia. Italia; 3Fondazione IRCCS Policlinico San Matteo, Pediatric Haematology Oncology, Pavia, Lombardia. Italia; 4Universita di Torino, Department of Clinical and Biological Sciences, Turín, Piemonte. Italia; 5Ospedale San Martino, Immuno-ematologia e Medicina Trasfusionale, Cerdeña. Italia; 6Fondazione IRCCS Policlinico San Matteo, Dipartimento di Medicina Diagnostica e dei Servizi, Pavia, Lombardia. Italia
[Annals of hepatology, México, 2016 Vol. 15 Num. 3 May-Jun, Pàg. 410-417]